Kanabo to present at Mello: 29 November 2021
Source: RNS
Kanabo Group Plc
("Kanabo" or "the Company")
Investor presentation - Mello Monday
Kanabo Group Plc (LSE:KNB), a leading processor and distributor of medical cannabis and CBD wellness products across Europe, will be presenting at Mello Monday on Monday 29th November 2021. Avihu Tamir, CEO, will be presenting at 8.00pm and taking questions from registered participants.
Kanabo is committed to ensuring best-in-class investor communications across all classes of investor so that its strategy, business model and financial performance are clearly available and understood.
If you would like to attend, register using the link below, using code SHVIP for 75% off tickets:
MelloMonday 29th November - Mello Events
For further information, please contact:
|
Kanabo Group Plc |
|
|
Avihu Tamir, CEO |
Via Vox Markets |
|
|
|
|
Peterhouse Capital Ltd |
|
|
Eran Zuckwer / Guy Miller (Financial Adviser) |
Tel: +44 (0)20 7469 0930 |
|
Lucy Williams / Charles Goodfellow (Corporate Broker) |
Tel: +44 (0)20 7469 0930 |
|
|
|
|
Vox Markets (Investor Relations) |
|
|
Kat Perez |
KanaboGroup@voxmarkets.co.uk |
About Kanabo Group Plc
Kanabo Group Plc is an R&D company currently selling a range of THC-Free Retail CBD Products in the Primary Markets and is in the process of developing further Medical Cannabis Products. The company's core strategy is to increase revenues from the sale of its Retail CBD Products in the wellness sector and to grow the Kanabo brand through its marketing initiatives.
Follow Kanabo and learn more here; https://www.voxmarkets.co.uk/listings/LON/KNB/
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach†in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
